See every side of every news story
Published loading...Updated

St. Jude Children’s Hospital’s Fundraising Arm Selects New CEO in Midst of Global Expansion

SHELBY COUNTY, TENNESSEE, JUL 8 – Ike Anand assumes CEO role to lead ALSAC's $12.9 billion six-year plan, aiming to advance cures and treatments for pediatric cancer worldwide, with $2.5 billion raised in 2024.

  • On Tuesday, ALSAC promoted Ike Anand to seventh CEO, following his interim role since March amid the organization’s global expansion and a $12.9 billion strategic plan.
  • Prompted by Richard C. Shadyac Jr.'s departure after 15 years, ALSAC's global search for a new CEO began last December, culminating in Anand's appointment this week.
  • ALSAC's $12.9 billion six-year plan launched in 2022, with over $2.5 billion raised in 2024, demonstrating its bold strategic ambitions.
  • Reactions from ALSAC’s board highlighted confidence, with Azar praising the appointment, Downing lauding Anand’s vision, and Habib calling it a new chapter.
  • Ike Anand's promotion as ALSAC's seventh CEO follows a global search initiated last December after Richard Shadyac Jr.'s departure, with the organization poised to expand globally under his leadership.
Insights by Ground AI
Does this summary seem wrong?

29 Articles

All
Left
10
Center
8
Right
6
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 42% of the sources lean Left
42% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Device News Magazine broke the news in on Tuesday, July 8, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.